Cancer Chemotherapy and Pharmacology

, Volume 65, Issue 5, pp 903–911

Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line

  • Karnati R. Roy
  • Gorla V. Reddy
  • Leela Maitreyi
  • Smita Agarwal
  • Chandrani Achari
  • Shireen Vali
  • Pallu Reddanna
Original Article

DOI: 10.1007/s00280-009-1097-3

Cite this article as:
Roy, K.R., Reddy, G.V., Maitreyi, L. et al. Cancer Chemother Pharmacol (2010) 65: 903. doi:10.1007/s00280-009-1097-3

Abstract

The role of COX-2 in the regulation of the expression of MDR1, a P-glycoprotein involved in hepatocellular carcinoma cell line, HepG2, was studied in the present investigation. Celecoxib, a selective inhibitor of COX-2, at 25 μM concentration increased the accumulation of doxorubicin in HepG2 cells and enhanced the sensitivity of the cells to doxorubicin by tenfold. The induction of MDR1 expression by PGE2 and its downregulation by celecoxib or by COX-2 knockdown suggests that the enhanced sensitivity of HepG2 cells to doxorubicin by celecoxib is mediated by the downregulation of MDR1 expression, through COX-2-dependent mechanism. Further studies revealed the involvement of AP-1 in the celecoxib-induced downregulation of MDR1 expression. These experimental studies correlated well with in silico predictions and further suggested the inactivation of the signal transduction pathways involving ERK, JNK and p38. The present study thus demonstrates the usefulness of COX-2 intervention in overcoming the drug resistance in HepG2 cells.

Keywords

AP-1CelecoxibCOX-2HepG2 cellsMDR1Simulation

Supplementary material

280_2009_1097_MOESM1_ESM.doc (30 kb)
Supplementary material 1 (DOC 30 kb)

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Karnati R. Roy
    • 1
  • Gorla V. Reddy
    • 1
  • Leela Maitreyi
    • 2
  • Smita Agarwal
    • 1
  • Chandrani Achari
    • 1
  • Shireen Vali
    • 2
  • Pallu Reddanna
    • 1
  1. 1.Department of Animal Sciences, School of Life SciencesUniversity of HyderabadHyderabadIndia
  2. 2.Cellworks Group Inc.CaliforniaUSA